Editorial: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have potential to transform health outcomes for persons with bipolar disorder, schizophrenia, major depressive disorder and other serious mental illnesses by lengthening healthspan and reducing excess and premature mortality
The takeaway is simple: "No DAC" is for mimicking natural, pulsatile GH release, making it the ideal partner for Ipamorelin in a synergistic blend
Our team will help you manage any side effects you may experience, making adjustments to minimize discomfort throughout your treatment
We cover dosing protocols, timing strategies, safety considerations, and sourcing guidance specifically for the Canadian market
However, patients and healthcare professionals have increasingly noted concerns about hair changes during treatment, prompting questions about whether these medications directly affect hair growth and follicle health